Doctors and patients now face uncertainty as the sudden discontinuation poses risks, including severe anemia. The lack of transparency from Pfizer and regulatory agencies raises concerns about patient ...

A man and woman, both with sickle cell, share what their experience was like finding love, and what prospective partners need ...

Earlier this year, STAT’s Eric Boodman reported the heartbreaking story of how, for decades, doctors have pressured sickle ...

Student Zoe Davis, 20, was just weeks into her junior year when she landed back in the hospital with severe sickle cell pain ...

A Johns Hopkins analysis commissioned by STAT shows that the rate of postpartum sterilization is significantly higher in ...

Current sickle cell disease treatment options include: A cornerstone of SCD treatment since 1988, hydroxyurea works by increasing the production of hemoglobin F, which helps prevent the formation of ...

The RUBY Trial is showing promise in treating patients fighting sickle cell disease, and Ohio is setting a national standard ...

(Bloomberg) -- European regulators suspended the approval of Pfizer Inc.’s sickle cell anemia drug, Oxbryta, citing a higher rate of disease complications in patients who started taking it.

SAFETY PROGRAM. TIME FOR FIVE ON YOUR HEALTH. WE’RE FOCUSING ON SICKLE CELL DISEASE. IT IS A PAINFUL, INHERITED CONDITION THAT PRIMARILY AFFECTS AFRICAN AMERICANS. HERE WITH SOME INSIGHT IS ...

Why Gene Therapy for Sickle Cell Is Slow to Catch on With Patients By Deena Beasley LOS ANGELES (Reuters) - Student Zoe Davis, 20, was just weeks into her junior year when she landed back in the ...

Adults with sickle cell disease (SCD) have an increased risk for stroke and transient ischemic attack (TIA), according to a study published online Sept. 20 in Blood. Olubusola Oluwole, M.D., from the ...